References
AHMAD, P.M., STIRLING, L.A., AHMAD, F., 1981. Partial Characterization
of Fatty Acid Synthase of Propionibacterium shermanii. Microbiology 127,
121–129. https://doi.org/10.1099/00221287-127-1-121
Arung, E.T., Wicaksono, B.D., Handoko, Y.A., Kusuma, I.W., Yulia, D.,
Sandra, F., 2009. Anti-Cancer Properties of Diethylether Extract of Wood
from Sukun (Artocarpus altilis) in Human Breast Cancer (T47D) Cells.
Tropical Journal of Pharmaceutical Research 8.
https://doi.org/10.4314/tjpr.v8i4.45223
Bhatt, A., Molle, V., Besra, G.S., Jacobs, W.R., Kremer, L., 2007. The
Mycobacterium tuberculosis FAS-II condensing enzymes: their role in
mycolic acid biosynthesis, acid-fastness, pathogenesis and in future
drug development. Mol. Microbiol. 64, 1442–1454.
https://doi.org/10.1111/j.1365-2958.2007.05761.x
Brusselmans, K., De Schrijver, E., Heyns, W., Verhoeven, G., Swinnen,
J.V., 2003. Epigallocatechin-3-gallate is a potent natural inhibitor of
fatty acid synthase in intact cells and selectively induces apoptosis in
prostate cancer cells. Int. J. Cancer 106, 856–862.
https://doi.org/10.1002/ijc.11317
Chalbos, D., Chambon, M., Ailhaud, G., Rochefort, H., 1987. Fatty acid
synthetase and its mRNA are induced by progestins in breast cancer
cells. J. Biol. Chem. 262, 9923–9926.
Deepa, P.R., Vandhana, S., Krishnakumar, S., 2013. Fatty acid synthase
inhibition induces differential expression of genes involved in
apoptosis and cell proliferation in ocular cancer cells. Nutr Cancer 65,
311–316. https://doi.org/10.1080/01635581.2013.748923
Dixit, R.B., Suseela, M.R., 2013. Cyanobacteria: potential candidates
for drug discovery. Antonie Van Leeuwenhoek 103, 947–961.
https://doi.org/10.1007/s10482-013-9898-0
Dutler, H., Kull, A., Mislin, R., 1971. Fatty acid synthetase from pig
liver. 2. Characterization of the enzyme complex with oxidoreductase
activity for alicyclic ketones as a fatty acid synthetase. Eur. J.
Biochem. 22, 213–217.
Filimonov, D.A., Akimov, D.V., Poroikov, V.V., 2004. The Method of
Self-Consistent Regression for the Quantitative Analysis of
Relationships Between Structure and Properties of Chemicals.
Pharmaceutical Chemistry Journal 38, 21–24.
https://doi.org/10.1023/B:PHAC.0000027639.17115.5d
Friesner, R.A., Murphy, R.B., Repasky, M.P., Frye, L.L., Greenwood,
J.R., Halgren, T.A., Sanschagrin, P.C., Mainz, D.T., 2006. Extra
precision glide: docking and scoring incorporating a model of
hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 49,
6177–6196. https://doi.org/10.1021/jm051256o
Gago, G., Diacovich, L., Arabolaza, A., Tsai, S.-C., Gramajo, H., 2011.
Fatty acid biosynthesis in actinomycetes. FEMS Microbiol. Rev. 35,
475–497. https://doi.org/10.1111/j.1574-6976.2010.00259.x
Kridel, S.J., Axelrod, F., Rozenkrantz, N., Smith, J.W., 2004. Orlistat
is a novel inhibitor of fatty acid synthase with antitumor activity.
Cancer Res. 64, 2070–2075.
Kuhajda, F.P., Jenner, K., Wood, F.D., Hennigar, R.A., Jacobs, L.B.,
Dick, J.D., Pasternack, G.R., 1994. Fatty acid synthesis: a potential
selective target for antineoplastic therapy. Proc. Natl. Acad. Sci.
U.S.A. 91, 6379–6383.
Kuhajda, F.P., Pizer, E.S., Li, J.N., Mani, N.S., Frehywot, G.L.,
Townsend, C.A., 2000. Synthesis and antitumor activity of an inhibitor
of fatty acid synthase. Proc. Natl. Acad. Sci. U.S.A. 97, 3450–3454.
https://doi.org/10.1073/pnas.050582897
Li, X.-C., Joshi, A.S., ElSohly, H.N., Khan, S.I., Jacob, M.R., Zhang,
Z., Khan, I.A., Ferreira, D., Walker, L.A., Broedel, S.E., Raulli, R.E.,
Cihlar, R.L., 2002. Fatty acid synthase inhibitors from plants:
isolation, structure elucidation, and SAR studies. J. Nat. Prod. 65,
1909–1914. https://doi.org/10.1021/np020289t
Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 2001.
Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Adv. Drug
Deliv. Rev. 46, 3–26.
Liu, B., Wang, Y., Fillgrove, K.L., Anderson, V.E., 2002. Triclosan
inhibits enoyl-reductase of type I fatty acid synthase in vitro and is
cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother.
Pharmacol. 49, 187–193. https://doi.org/10.1007/s00280-001-0399-x
Liu, H., Liu, J.-Y., Wu, X., Zhang, J.-T., 2010. Biochemistry, molecular
biology, and pharmacology of fatty acid synthase, an emerging
therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol
Biol 1, 69–89.
Loftus, T.M., Jaworsky, D.E., Frehywot, G.L., Townsend, C.A., Ronnett,
G.V., Lane, M.D., Kuhajda, F.P., 2000. Reduced food intake and body
weight in mice treated with fatty acid synthase inhibitors. Science 288,
2379–2381.
Lupu, R., Menendez, J.A., 2006. Pharmacological inhibitors of Fatty Acid
Synthase (FASN)–catalyzed endogenous fatty acid biogenesis: a new
family of anti-cancer agents? Curr Pharm Biotechnol 7, 483–493.
Maier, T., Leibundgut, M., Boehringer, D., Ban, N., 2010. Structure and
function of eukaryotic fatty acid synthases. Q. Rev. Biophys. 43,
373–422. https://doi.org/10.1017/S0033583510000156
Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra,
G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., Fiore, C.,
Xie, W., Kung, A.L., Febbo, P.G., Subramanian, A., Mucci, L., Ma, J.,
Signoretti, S., Stampfer, M., Hahn, W.C., Finn, S., Loda, M., 2009.
Fatty acid synthase: a metabolic enzyme and candidate oncogene in
prostate cancer. J. Natl. Cancer Inst. 101, 519–532.
https://doi.org/10.1093/jnci/djp030
Moche, M., Schneider, G., Edwards, P., Dehesh, K., Lindqvist, Y., 1999.
Structure of the complex between the antibiotic cerulenin and its
target, beta-ketoacyl-acyl carrier protein synthase. J. Biol. Chem. 274,
6031–6034.
Ohno, T., Awaya, J., Kesado, T., Nomura, S., Ōmura, S., 1974. Mechanism
of Action of CM-55, a Synthetic Analogue of the Antilipogenic Antibiotic
Cerulenin. Antimicrob Agents Chemother 6, 387–392.
Pappenberger, G., Benz, J., Gsell, B., Hennig, M., Ruf, A., Stihle, M.,
Thoma, R., Rudolph, M.G., 2010. Structure of the human fatty acid
synthase KS-MAT didomain as a framework for inhibitor design. J. Mol.
Biol. 397, 508–519. https://doi.org/10.1016/j.jmb.2010.01.066
Rendina, A.R., Cheng, D., 2005. Characterization of the inactivation of
rat fatty acid synthase by C75: inhibition of partial reactions and
protection by substrates. Biochem. J. 388, 895–903.
https://doi.org/10.1042/BJ20041963
Trajtenberg, F., Altabe, S., Larrieux, N., Ficarra, F., de Mendoza, D.,
Buschiazzo, A., Schujman, G.E., 2014. Structural insights into bacterial
resistance to cerulenin. FEBS J. 281, 2324–2338.
https://doi.org/10.1111/febs.12785
Vazquez-Martin, A., Colomer, R., Brunet, J., Lupu, R., Menendez, J.A.,
2008. Overexpression of fatty acid synthase gene activates HER1/HER2
tyrosine kinase receptors in human breast epithelial cells. Cell Prolif.
41, 59–85. https://doi.org/10.1111/j.1365-2184.2007.00498.x
von Wettstein-Knowles, P., Olsen, J.G., McGuire, K.A., Henriksen, A.,
2006. Fatty acid synthesis. Role of active site histidines and lysine in
Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases. FEBS J.
273, 695–710. https://doi.org/10.1111/j.1742-4658.2005.05101.x
Wakil, S.J., 1989. Fatty acid synthase, a proficient multifunctional
enzyme. Biochemistry 28, 4523–4530. https://doi.org/10.1021/bi00437a001
Wang, Y.Y., Kuhajda, F.P., Li, J., Finch, T.T., Cheng, P., Koh, C., Li,
T., Sokoll, L.J., Chan, D.W., 2004. Fatty acid synthase as a tumor
marker: its extracellular expression in human breast cancer. J. Exp.
Ther. Oncol. 4, 101–110.
White, S.W., Zheng, J., Zhang, Y.-M., Rock, null, 2005. The structural
biology of type II fatty acid biosynthesis. Annu. Rev. Biochem. 74,
791–831. https://doi.org/10.1146/annurev.biochem.74.082803.133524
Wijffels, R.H., Kruse, O., Hellingwerf, K.J., 2013. Potential of
industrial biotechnology with cyanobacteria and eukaryotic microalgae.
Curr. Opin. Biotechnol. 24, 405–413.
https://doi.org/10.1016/j.copbio.2013.04.004
Zhou, W., Simpson, P.J., McFadden, J.M., Townsend, C.A., Medghalchi,
S.M., Vadlamudi, A., Pinn, M.L., Ronnett, G.V., Kuhajda, F.P., 2003.
Fatty acid synthase inhibition triggers apoptosis during S phase in
human cancer cells. Cancer Res. 63, 7330–7337.